Protective effects of resveratrol on postmenopausal osteoporosis: regulation of SIRT1-NF-κB signaling pathway

Osteogenic effects of resveratrolin vitro: potential for the prevention and treatment of osteoporosis

(2013) Ali Mobasheri et al.   Annals of the New York Academy of Sciences

The effect of regular physical activity on bone mineral density in post-menopausal women aged 75 and over: a retrospective analysis from the Canadian multicentre osteoporosis study

(2013) Jeffrey M Muir et al.   BMC MUSCULOSKELETAL DISORDERS

Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus

(2013) Haifeng Zhao et al.   BRITISH JOURNAL OF NUTRITION

TNF-α triggers osteogenic differentiation of human dental pulp stem cells via the NF-κB signalling pathway

(2013) Xingmei Feng et al.   CELL BIOLOGY INTERNATIONAL

Management of Metastatic Bone Disease in the Elderly with Bisphosphonates and Receptor Activator of NF-kB Ligand Inhibitors: Effectiveness and Safety

(2013) Vassilios Vassiliou   CLINICAL ONCOLOGY

Effect of methylprednisolone on bone mineral density in rats with ovariectomy-induced bone loss and suppressed endogenous adrenaline levels by metyrosine

(2013) Mehmet Yilmaz et al.   INDIAN JOURNAL OF PHARMACOLOGY

Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells

(2013) Dong-Zhu Li et al.   JOURNAL OF BONE AND MINERAL METABOLISM

NF-κB RelB Negatively Regulates Osteoblast Differentiation and Bone Formation

(2013) Zhenqiang Yao et al.   JOURNAL OF BONE AND MINERAL RESEARCH

KMUP-1 Suppresses RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss: Roles of MAPKs, Akt, NF-κB and Calcium/Calcineurin/NFATc1 Pathways

(2013) Shu-Fen Liou et al.   PLoS One

SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential

(2013) Munehiro Kitada et al.   Diabetes & Metabolism Journal

Perspectives on translational and therapeutic aspects of SIRT1 in inflammaging and senescence

(2012) Hongwei Yao et al.   BIOCHEMICAL PHARMACOLOGY

Seven sirtuins for seven deadly diseases ofaging

(2012) Brian J. Morris   FREE RADICAL BIOLOGY AND MEDICINE

Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways

(2012) H.-B. Hsiao et al.   OSTEOPOROSIS INTERNATIONAL

Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF-κB Ligand (RANKL) Activation of NF-κB Signaling and Inhibit Osteoclastogenesis in Bone-derived Cells

(2011) Mehdi Shakibaei et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Resveratrol effect on osteogenic differentiation of rat and human adipose derived stem cells in a 3-D culture environment

(2011) Christopher R. Dosier et al.   Journal of the Mechanical Behavior of Biomedical Materials

SIRT1 as a therapeutic target in inflammaging of the pulmonary disease

(2011) Irfan Rahman et al.   PREVENTIVE MEDICINE

Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production

(2010) Xu He et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Early Apoptotic Vascular Signaling is Determined by Sirt1 Through Nuclear Shuttling, Forkhead Trafficking, Bad, and Mitochondrial Caspase Activation

(2010) Jinling Hou et al.   CURRENT NEUROVASCULAR RESEARCH

Suppression of NF-κB Increases Bone Formation and Ameliorates Osteopenia in Ovariectomized Mice

(2010) Neil Alles et al.   ENDOCRINOLOGY